Percheron Therapeutics Ltd
ASX:PER
Percheron Therapeutics Ltd
ASX:PER
Price:
0.005
AUD
Market Closed
Market Cap:
AU$7.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
|
B
|
Bougainville Copper Ltd
ASX:BOC
|
PG |
|
Pressman Advertising Ltd
NSE:PRESSMN
|
IN |
|
E
|
Evolve Education Group Ltd
ASX:EVO
|
NZ |
|
Cimentas Izmir Cimento Fabrikasi TAS
IST:CMENT.E
|
TR |
|
Cassius Mining Ltd
ASX:CMD
|
AU |
|
P
|
Pattern Group Inc
NASDAQ:PTRN
|
US |
|
A
|
AiXin Life International Inc
OTC:AIXN
|
CN |
|
HF Company SA
F:HFC
|
FR |
|
NORDWEST Handel AG
F:NWX
|
DE |
|
Biomea Fusion Inc
NASDAQ:BMEA
|
US |
|
V
|
VGI PCL
SET:VGI
|
TH |
|
Siegfried Holding AG
SIX:SFZN
|
CH |
|
Ferrovial SA
MAD:FER
|
ES |
|
E
|
Eco Wave Power Global AB (publ)
NASDAQ:WAVE
|
SE |
|
D
|
Duong Hieu Trading and Mining JSC
VN:DHM
|
VN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PER's stock price target?
Not Available
PER does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Percheron Therapeutics Ltd?
Projected CAGR
53%
53%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 2 years is 53%.
